Then, we constructed a nomogram based on the significant correlation of MFAP4 level, WHO grade, IDH genotype, 1p/19q codeletion, primary therapy outcome, and age, and determined that these metrics had a significant correlation with patients’ prognosis by multifactorial analysis, and we found that the nomogram was effective in predicting 1-, 3-, and 5-year survival rates of glioma patients (Figure 3C). Here, MFAP4 is linked to glioma.